This article is more than 5 years old. Information may no longer be current.

Rotation Medical secures $27.2 million financing agreement

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Rotation Medical recently announced it has secured $27.2 million in an oversubscribed Series B financing. 

The financing comes via a conglomerate of Life Sciences Partners, New Enterprise Associates and Pappas Ventures, among others, according to a company press release.

Rotation Medical plans to use the funding to support the commercial launch and clinical studies of the company’s rotator cuff system, which comprises a bioinductive implant and disposable instruments that allow for both mini-open and arthroscopic procedures. The rotator cuff system is expected to be launched later this year.

The company also announced that representatives from Life Sciences Partners and Pappas Ventures will also join the Rotation Medical Board of Directors, according to the release.